5 unchanged sentences
Certificate of Amendment of Amended and Restated Certificate of Incorporation of the Registrant, effective as of December 23, 2020 (incorporated herein by reference to Registrant's Current Report on Form 8-K as filed with the SEC on December 23, 2020).
−Removed: Certificate of Elimination of Series A Convertible Preferred Stock of KemPharm, Inc.
−Removed: (incorporated herein by reference to the Registrant's Current Report on Form 8-K as filed with the SEC on June 23, 2021).
−Removed: Certificate of Elimination of Series B-1 Convertible Preferred Stock of KemPharm, Inc.
−Removed: (incorporated herein by reference to the Registrant's Current Report on Form 8-K as filed with the SEC on June 23, 2021).
−Removed: Certificate of Elimination of Series B-2 Convertible Preferred Stock of KemPharm, Inc.
−Removed: (incorporated herein by reference to the Registrant's Current Report on Form 8-K as filed with the SEC on June 23, 2021).
Amended and Restated Bylaws, as currently in effect, of KemPharm, Inc.
2 unchanged sentences
Exhibit 3.2  hereof.
−Removed: Form of Inducement Warrant (incorporated herein by reference to the Registrant's Current Report on Form 8-K as filed with the SEC on June 23, 2021).
−Removed: Amendment No.
−Removed: 1 to Collaboration and License Agreement, effective as of April 8, 2021, by and between the Company and Commave Therapeutics SA.
−Removed: Form of Inducement Letter  
−Removed: (incorporated herein by reference to the Registrant's Current Report on Form 8-K as filed with the SEC on June 23, 2021).
−Removed: Equity Distribution Agreement, dated July 2, 2021, by and among the Company, JMP Securities LLC and RBC Capital Markets, LLC (incorporated herein by reference to the Registrant's Current Report on Form 8-K as filed with the SEC on July 2, 2021).
−Removed: Amended and Restated 2014 Equity Incentive Plan.
−Removed: 2021 Employee Stock Purchase Plan.
+Added: Equity Distribution Agreement, dated July 2, 2021, by and among the Registrant, JMP Securities LLC and RBC Capital Markets, LLC (incorporated herein by reference to the Registrant's Current Report on Form 8-K as filed with the SEC on July 2, 2021).
Certification of the Principal Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934, as amended.
12 unchanged sentences
Filed herewith
−Removed: Attached as Exhibit 101 to this Quarterly Report on Form 10-Q for the quarter ended June 30, 2021, formatted in XBRL (Extensible Business Reporting Language):
+Added: Attached as Exhibit 101 to this Quarterly Report on Form 10-Q for the quarter ended September 30, 2021, formatted in XBRL (Extensible Business Reporting Language):
(i) Unaudited Condensed Balance Sheets, (ii) Unaudited Condensed Statements of Operations, (iii) Unaudited Condensed Statements of Changes in Stockholders' Deficit, (iv) Unaudited Condensed Statements of Cash Flows, and (v) Notes to Unaudited Condensed Financial Statements, tagged as blocks of text and including detailed tags.
−Removed: Pursuant to Item 601(b)(10) of Regulation S-K, certain confidential portions of this exhibit have been omitted by means of marking such portions with asterisks [***] as the identified confidential portions (i) are not material and (ii) the Registrant customarily and actually treats that information as private or confidential.
−Removed: Indicates management contract or compensatory plan.
This certification accompanies the Quarterly Report on Form 10-Q to which it relates, is not deemed filed with the SEC and is not to be incorporated by reference into any filing of the Registrant under the Securities Act or the Exchange Act (whether made before or after the date of the Quarterly Report on Form 10-Q), irrespective of any general incorporation language contained in such filing.
2 unchanged sentences
KemPharm, Inc.
−Removed: August 13, 2021
+Added: November 10, 2021
/s/ Travis C.
2 unchanged sentences
(Principal Executive Officer)
−Removed:       August 13, 2021
+Added:       November 10, 2021
LaDuane Clifton
3 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.